Medigus Receivables

Medigus (MDGS) currently reports a receivables of $16M as of December 2023. That compares with $25M in the prior-year period — down 38.0% year over year. Use the charts on this page to explore Medigus's receivables history and peer comparisons.

Medigus's receivables decreased from $25M to $16M — a 38.0% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Medigus reported $16M in receivables as of December 2023. That compares with $25M in the prior-year period — down 38.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Medigus, and consider following MDGS for alerts when major investors trade the stock.

Medigus is classified in the Healthcare sector. On receivables, it currently shows $16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MDGS with unrelated industries.